判斷轉移性大腸直腸癌風險、預後程度的方法及其生物標記

Translated title of the contribution: METHOD AND BIOMARKERS FOR ASSESSING THE RISK AND PROGNOSIS OF METASTATIC COLORECTAL CANCER
  • Jau-Song Yu (Inventor)
  • , Bertrand Chin-Ming Tan (Inventor)
  • , Hsuan Liu (Inventor)
  • , Chia-Yu Yang (Inventor)
  • , Ian Yi-Feng Chang (Inventor)
  • , Chi Yang (Inventor)
  • , YI-TUNG CHEN (Inventor)
  • , HUNG-CHIH HSU (Inventor)
  • , YING-YU LAI (Inventor)
  • , YU-HAO LIU (Inventor)
  • , CHUNG-PEI MA (Inventor)
  • , WEN-SY TSAI (Inventor)
  • , CHAN-KENG YANG (Inventor)

Research output: Patent

Abstract

This invention unveils a method and associated biomarkers for assessing the risk and prognostic level of metastatic colorectal cancer. The evaluation is made by observing the expression levels of EV-miR-320c in extracellular vesicles (EV), identified as the biomarker in this invention. This measure helps determine the risk of an individual developing metastatic colorectal cancer. Furthermore, post-treatment, the expression levels of EV-miR-320c in EVs can be used to monitor the progression of the disease. The detection and monitoring methodology leveraging EV-miR-320c in EVs demonstrated high sensitivity and specificity.
Translated title of the contributionMETHOD AND BIOMARKERS FOR ASSESSING THE RISK AND PROGNOSIS OF METASTATIC COLORECTAL CANCER
Original languageChinese (Traditional)
IPCC12Q 1/6886(2018.01)
StatePublished - 16 01 2025

Bibliographical note

公開公告號: 202503070
Announcement ID: 202503070

Fingerprint

Dive into the research topics of 'METHOD AND BIOMARKERS FOR ASSESSING THE RISK AND PROGNOSIS OF METASTATIC COLORECTAL CANCER'. Together they form a unique fingerprint.

Cite this